Sign inJoin waitlistJoin the waitlist

Joseph Galati

Director, Liver Specialists of Texas · Baylor College of Medicine

Credentials: · · · ·

History

Baylor College of Medicine
Present

Gastroenterology
SUNY Downstate Health Sciences University
1988–1991
Internal Medicine
University of Nebraska Medical Center College of Medicine
1988–1991
SUNY Downstate Health Sciences University
1987–1988
ST GEORGE'S UNIV SCH OF MED, ST GEORGE'S, GRENADA
1983–1987
Syracuse University

Research

Peginterferon alfa-2b or alfa-2a with ribavirin for treatment of hepatitis C infection
New England Journal of Medicine · 2009 · 987 citations
Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection…
The Lancet · 2010 · 535 citations
Predicting poor outcome following hepatectomy: analysis of 2313 hepatectomies in the NSQIP database
HPB · 2009 · 163 citations

HM
Howard Monsour
6 papers
Mark Ghobrial
6 papers
Osama Gaber
5 papers
Ashish Saharia
4 papers
Eamonn Quigley
4 papers
MS
Mark Sulkowski
4 papers
Victor Ankoma-Sey
4 papers
Alexander Kuo
3 papers
CO
Claire Ozaki
3 papers
David Nelson
3 papers
David Victor
3 papers
Eric Lawitz
3 papers

Clinical trials

A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
Site PI · Recruiting · Phase 3
GlaxoSmithKline
2025–2031
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
Site PI · Recruiting · Phase 3
Eli Lilly and Company
2025–2032
A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH
Site PI · Recruiting · Phase 2
GlaxoSmithKline
2025–2028